Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...

Cystic Fibrosis is a rare autosomal recessive disease that causes sticky mucus to build up in the lungs, affecting numerous ...

The small molecule CFTR modulators market targets cystic fibrosis treatment, driven by innovative therapies, rising prevalence ...

Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® ...

North Carolina man created a foundation to help other patients navigate expenses of an unexpectedly longer life ...

A small group of Australians with the rarest kinds of cystic fibrosis – fewer than 200 people – will, for the first time, ...

When faced with the myriad diseases and equally numerous targets for potential drugs the company could pursue, Kewalramani ...

More Australians living with rarer types of cystic fibrosis will be able to access treatment for the first time when expanded ...

Cystic fibrosis treatments require several hours a day, so the treatment burden may be challenging and impact the time and energy patients have to work or have a personal life.